Paper

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

Published Feb 1, 2001 · L. Lundell, J. Hatlebakk, H. Myrvold

Journal of the American College of Surgeons

365

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Large Human Trial

Highly Cited

Study Snapshot

Antireflux surgery is more effective than omeprazole in controlling gastroesophageal reflux disease, but when doses are adjusted for relapse, the two therapies show similar efficacy levels.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

References

Citations